Please login to the form below

Not currently logged in
Email:
Password:

market access

This page shows the latest market access news and features for those working in and with pharma, biotech and healthcare.

Spirit Health Group offers new market access consultancy service

Spirit Health Group offers new market access consultancy service

Spirit Health Group offers new market access consultancy service. Spirit Access will support the pharmaceutical and device industries. ... Following the acquisition of a majority stake in patient pathway and healthcare development company Pathway

Latest news

  • Segmentation, evolved Segmentation, evolved

    a cluster of adaptations - from early market access involvement to re-engineered metrics - that I’ve observed in the evolution of various innovation-based life science business models. ... Research by Amgen, which has a PCSK9 called Repatha, suggests

  • NHS seeks 'solution creators' from within pharma NHS seeks 'solution creators' from within pharma

    Addressing IQVIA’s UK Market Access Summit he said: “Not withstanding the cold trade winds of Brexit, which I totally understand, I would content that we are moving into a new ... or patient access schemes.

  • Alex Butler and Matt Baker launch Foundry3 Alex Butler and Matt Baker launch Foundry3

    Before moving agency-side in 2011, he spent more than a decade within pharma, including six years at J&J in various market access, marketing, communications and digital strategy roles. ... To navigate the complexities of today’s healthcare market, we

  • 2018 by Darwin 2018 by Darwin

    There are many reasons for this but a common one is that would-be innovative business models often fall into the market access trough. ... But the market access trough is only one of many ‘fitness troughs’in our industry’s landscape.

  • Vertex’s Orkambi receives EU green light for licence extension Vertex’s Orkambi receives EU green light for licence extension

    Simon Bedson, senior vice president and international general manager at Vertex was keen to highlight the market access work the company has undertaken to help it reach patients. ... He said: “The innovative long-term agreements we have reached in

More from news
Approximately 108 fully matching, plus 417 partially matching documents found.

Latest Intelligence

  • A marathon and a sprint A marathon and a sprint

    We may eventually see a complete role reversal where market access, medical and government affairs become the ‘external faces’of organisations, with commercial teams becoming more strategic and inwardly focused. ... That can easily translate to pharma

  • Market access

    Healthcare terms - Market access.

  • Healthcare Glossary

    Search and browse hundreds of industry specific terms and phrases or suggest your own terms and definitions. Balanced Scorecard. A management tool used by organisations to monitor and manage performance against defined objectives. It began as a

  • Flight path: the long-haul journey Flight path: the long-haul journey

    Today’s strategic plans must leverage the knowledge of - and continually engage - multi-disciplinary teams that bridge the likes of medical, marketing, market access, sales and business intelligence. ... If you don’t have good visibility or access to

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    Digital biomarkers provide access to new types of insights and offer unique advantages by allowing data to be generated frequently and as part of the patient’s daily life. ... An understanding of these factors can inform a digital biomarker development

More from intelligence
Approximately 52 fully matching, plus 110 partially matching documents found.

Latest appointments

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications. ... In this role, Hurrell oversaw the team’s market access communications offering, supporting

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Open Health creates new role Open Health creates new role

    In order to strengthen their experience and expertise, healthcare communications and market access group Open Health has appointed Gavin Jones into its newly formed role of director of rare disease. ... Joining the agency with twenty

  • Acumen appoints new strategy director Acumen appoints new strategy director

    Bols has also worked in the areas of market access, government affairs, public affairs, health policy and corporate communications to name a few and he has also advised companies engaging with

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Hughes-Wilson brings in-depth market access and product launch expertise as well as a proven ability to develop and lead commercial planning efforts globally. ... Prior to this, she served as vice president of health and market access policy at Genzyme

More from appointments
Approximately 4 fully matching, plus 84 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 25 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics